Bank Julius Baer & Co’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-508
Closed -$5K 817
2021
Q2
$5K Buy
508
+8
+2% +$73 ﹤0.01% 799
2021
Q1
$5K Sell
500
-1,073
-68% -$8.85K ﹤0.01% 794
2020
Q4
$7K Buy
1,573
+74
+5% +$335 ﹤0.01% 774
2020
Q3
$6K Sell
1,499
-4,001
-73% -$28.5K ﹤0.01% 697
2020
Q2
$49K Sell
5,500
-17
-0.3% -$86 ﹤0.01% 567
2020
Q1
$19K Buy
+5,517
New +$25.6K ﹤0.01% 584

Other funds holding DVAX

Bank Julius Baer & Co's DVAX Position: Q3 2021 in Review

Bank Julius Baer & Co sold out of Dynavax Technologies (DVAX) in Q3 2021, closing a stake of 508 shares — an estimated $5K sold.

Bank Julius Baer & Co first reported a position in DVAX in Q1 2020 and held it in 6 quarters. The position peaked at $49K in Q2 2020. 183 funds tracked by Wall St. Rank hold DVAX as of Q3 2021.

  • Bank Julius Baer & Co reported no remaining Dynavax Technologies position as of Q3 2021 after selling out during the quarter.
  • Bank Julius Baer & Co sold 508 Dynavax Technologies shares in Q3 2021, an estimated $5K.
  • Bank Julius Baer & Co first reported a position in Dynavax Technologies in Q1 2020 and held it in 6 quarters.
  • Bank Julius Baer & Co's Dynavax Technologies position peaked at $49K in Q2 2020.
  • 183 funds tracked by Wall St. Rank held Dynavax Technologies as of Q3 2021.

Based on Bank Julius Baer & Co's 13F filing for Q3 2021, filed 12 Nov 2021.